Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2019

Jul 12, 2019

SELL
$44.62 - $49.34 $446,200 - $493,400
-10,000 Closed
0 $0
Q1 2019

Apr 15, 2019

BUY
$45.12 - $53.8 $451,200 - $538,000
10,000 New
10,000 $477,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Havens Advisors LLC Portfolio

Follow Havens Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Havens Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Havens Advisors LLC with notifications on news.